Comprehensive management of the renal-transplant recipient

Abstract

Renal transplantation (RT) is the current treatment of choice for patients with end-stage renal disease (ESRD). Innovations in RT and immunosuppressive regimens have greatly improved both the patient and graft survival. A successful RT offers enhanced quality and duration of life and is more effective (medically and economically) than long-term dialysis therapy for patients with ESRD. Close follow-up and monitoring treatment are the important part of the management of RT recipients (RTRs). Cardiovascular disease, infections, and drug toxicity play a key role in the long-term morbidity and mortality of this patient population. As RTRs survive for longer periods of time with functioning allografts, physicians will likely become more involved in their management, mandating at least a basic understanding of management of an adult RTR.